- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Viking Therapeutics (NASDAQ:VKTX), Quotes and News Summary
Viking Therapeutics (NASDAQ: VKTX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-07-27 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.190 | -0.210 | -0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Viking Therapeutics Questions & Answers
You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.
Other companies in Viking Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), AVEO Pharmaceuticals (NASDAQ:AVEO), Outlook Therapeutics (NASDAQ:OTLK) and Impel Pharmaceuticals (NASDAQ:IMPL).
The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by SVB Leerink on Thursday, April 28, 2022. The analyst firm set a price target for 12.00 expecting VKTX to rise to within 12 months (a possible 315.22% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $2.89 last updated Today at July 5, 2022, 4:15 PM UTC.
There are no upcoming dividends for Viking Therapeutics.
Viking Therapeutics’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.